JW Lifescience Temettü
Temettü kriter kontrolleri 4/6
JW Lifescience is a dividend paying company with a current yield of 4.58% that is well covered by earnings.
Anahtar bilgiler
4.6%
Temettü verimi
n/a
Geri Alım Getirisi
| Toplam Hissedar Getirisi | n/a |
| Gelecekteki Temettü Verimi | n/a |
| Temettü Büyümesi | 16.5% |
| Bir sonraki temettü ödeme tarihi | n/a |
| Eski temettü tarihi | n/a |
| Hisse başına temettü | ₩500.000 |
| Ödeme oranı | 29% |
Son temettü güncellemeleri
Recent updates
We Think JW Lifescience (KRX:234080) Can Manage Its Debt With Ease
Apr 20
Introducing JW Lifescience (KRX:234080), A Stock That Climbed 36% In The Last Year
Mar 11What Type Of Shareholders Make Up JW Lifescience Corporation's (KRX:234080) Share Registry?
Feb 21Is JW Lifescience Corporation (KRX:234080) A Smart Pick For Income Investors?
Feb 02
We Think JW Lifescience (KRX:234080) Can Manage Its Debt With Ease
Jan 12Is It Smart To Buy JW Lifescience Corporation (KRX:234080) Before It Goes Ex-Dividend?
Dec 23Is JW Lifescience Corporation's (KRX:234080) Recent Performance Tethered To Its Attractive Financial Prospects?
Dec 23How Much Did JW Lifescience's(KRX:234080) Shareholders Earn From Share Price Movements Over The Last Three Years?
Nov 27Ödemelerde İstikrar ve Büyüme
Temettü verilerini getirme
İstikrarlı Temettü: Whilst dividend payments have been stable, A234080 has been paying a dividend for less than 10 years.
Büyüyen Temettü: A234080 has only been paying a dividend for 6 years, and since then payments have not increased.
Piyasaya Karşı Temettü Getirisi
| JW Lifescience Piyasaya Karşı Temettü Getirisi |
|---|
| Segment | Temettü Verimi |
|---|---|
| Şirket (A234080) | 4.6% |
| Pazarın Alt %25'i (KR) | 1.2% |
| Pazarın En İyi %25'i (KR) | 3.8% |
| Sektör Ortalaması (Pharmaceuticals) | 1.0% |
| Analist tahmini (A234080) (3 yıla kadar) | n/a |
Önemli Temettü: A234080's dividend (4.58%) is higher than the bottom 25% of dividend payers in the KR market (1.18%).
Yüksek Temettü: A234080's dividend (4.58%) is in the top 25% of dividend payers in the KR market (3.75%)
Hissedarlara Ödenen Kazanç
Kazanç Kapsamı: With its reasonably low payout ratio (29.1%), A234080's dividend payments are well covered by earnings.
Hissedarlara Nakit Ödeme
Nakit Akışı Kapsamı: With its reasonably low cash payout ratio (47.5%), A234080's dividend payments are well covered by cash flows.